Hyundai Bioscience Co. Ltd (048410) — Strategic Asset Allocation Index
Hyundai Bioscience Co. Ltd (048410) has a Strategic Asset Allocation Index of 6.0% as of September 2024. Strategic assets (PP&E of ₩2.64 Billion plus long-term investments of ₩-) total ₩2.64 Billion, measured against net assets of ₩43.74 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 048410 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Hyundai Bioscience Co. Ltd Strategic Asset Allocation Index (2002–2022)
This chart shows how Hyundai Bioscience Co. Ltd's Strategic Asset Allocation Index has evolved across 20 annual periods from 2002 to 2022. As of September 2024, the index stands at 6.0%, representing strategic assets of ₩2.64 Billion against net assets of ₩43.74 Billion KRW. See financial flexibility index of Hyundai Bioscience Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Hyundai Bioscience Co. Ltd (2002–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Hyundai Bioscience Co. Ltd from 2002 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Hyundai Bioscience Co. Ltd.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 10.9% | ₩6.38 Billion | ₩6.38 Billion | ₩- | ₩58.24 Billion | ▲ +1.1 pp |
| 2021 | 9.9% | ₩6.07 Billion | ₩6.07 Billion | ₩- | ₩61.57 Billion | ▼ -3.2 pp |
| 2020 | 13.0% | ₩6.67 Billion | ₩6.67 Billion | ₩- | ₩51.22 Billion | ▼ -6.5 pp |
| 2019 | 19.5% | ₩9.17 Billion | ₩7.20 Billion | ₩1.97 Billion | ₩46.99 Billion | ▼ -4.0 pp |
| 2018 | 23.5% | ₩9.53 Billion | ₩8.37 Billion | ₩1.16 Billion | ₩40.48 Billion | ▼ -8.9 pp |
| 2017 | 32.4% | ₩10.01 Billion | ₩9.44 Billion | ₩571.51 Million | ₩30.89 Billion | ▼ -27.2 pp |
| 2016 | 59.6% | ₩10.85 Billion | ₩10.08 Billion | ₩773.38 Million | ₩18.21 Billion | ▲ +35.1 pp |
| 2015 | 24.5% | ₩6.02 Billion | ₩5.42 Billion | ₩600.25 Million | ₩24.60 Billion | ▼ -3.6 pp |
| 2014 | 28.1% | ₩6.31 Billion | ₩5.71 Billion | ₩600.25 Million | ₩22.49 Billion | ▲ +1.9 pp |
| 2013 | 26.2% | ₩5.71 Billion | ₩5.71 Billion | ₩- | ₩21.80 Billion | ▼ -11.8 pp |
| 2012 | 37.9% | ₩7.17 Billion | ₩7.17 Billion | ₩- | ₩18.90 Billion | ▲ +1.6 pp |
| 2011 | 36.3% | ₩5.15 Billion | ₩5.15 Billion | ₩- | ₩14.17 Billion | ▲ +15.7 pp |
| 2010 | 20.6% | ₩6.60 Billion | ₩6.60 Billion | ₩- | ₩32.08 Billion | ▲ +1.0 pp |
| 2009 | 19.5% | ₩7.68 Billion | ₩7.68 Billion | ₩- | ₩39.30 Billion | ▲ +5.9 pp |
| 2008 | 13.6% | ₩6.87 Billion | ₩6.87 Billion | ₩- | ₩50.36 Billion | ▲ +5.7 pp |
| 2007 | 8.0% | ₩4.65 Billion | ₩4.65 Billion | ₩- | ₩58.24 Billion | ▼ -35.5 pp |
| 2005 | 43.5% | ₩17.10 Billion | ₩17.10 Billion | ₩- | ₩39.33 Billion | ▲ +11.8 pp |
| 2004 | 31.7% | ₩19.33 Billion | ₩19.33 Billion | ₩- | ₩60.94 Billion | ▲ +5.0 pp |
| 2003 | 26.8% | ₩18.30 Billion | ₩18.30 Billion | ₩- | ₩68.34 Billion | ▼ -3.3 pp |
| 2002 | 30.1% | ₩19.26 Billion | ₩19.26 Billion | ₩- | ₩64.08 Billion | — |